drugset / Trial / NCT03796507
Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the feasibility of a possible treatment regimen that could be used to delay tumor progression in patients with glioblastoma. The study is being conducted in patients who qualify for inpatient rehabilitation, as this population is particularly vulnerable to delays in initiation of chemoradiation and further tumor growth in the period between surgical resection and the start of treatment.
Timeline
- Start
- 2021-09-01
- Primary completion
- 2021-12-15
- Completion
- 2021-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 75 mg/m2 | Oral |